Axon (AXON) CEO Patrick Smith sells 10,000 shares, holds 3,090,997

Rhea-AI Filing Summary

AXON ENTERPRISE, INC. chief executive officer and director Patrick W. Smith reported an open-market sale of 10,000 shares of common stock. The transaction occurred on February 25, 2026 at a price of $500.24 per share and was coded as a sale.

The filing states that this transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Smith on May 12, 2025. After this sale, Smith directly holds 3,090,997 shares of Axon common stock.

Insider Trade Summary

Net Seller: 10,000 shares ($5,002,400)

Net Sell 1 txn

Insider SMITH PATRICK W

Role CHIEF EXECUTIVE OFFICER

Sold 10,000 shs ($5.00M)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,000	$500.24	$5.00M

Holdings After Transaction: Common Stock — 3,090,997 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SMITH PATRICK W

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		S(1)		10,000	D	$500.24	3,090,997	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

Remarks:

	/s/ Patrick W. Smith by Isaiah Fields, Attorney-in-Fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AXON CEO Patrick W. Smith report in this Form 4?

Patrick W. Smith reported selling 10,000 shares of Axon common stock. The sale was an open-market transaction executed on February 25, 2026, and is disclosed as a Rule 10b5-1 plan trade in the Form 4 filing.

At what price did AXON CEO Patrick W. Smith sell his 10,000 shares?

The 10,000 Axon common shares were sold at a price of $500.24 per share. This price is explicitly listed in the Form 4 and applies to the non-derivative open-market sale reported for February 25, 2026.

How many AXON shares does Patrick W. Smith hold after this reported sale?

After the reported sale, Patrick W. Smith directly holds 3,090,997 shares of Axon common stock. This post-transaction ownership figure is provided in the Form 4 as the total shares beneficially owned following the transaction.

Was the AXON CEO’s 10,000-share sale under a Rule 10b5-1 trading plan?

Yes, the Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan. The filing specifies that Patrick W. Smith adopted this plan on May 12, 2025, and the reported sale was executed under that plan.

What type of security did AXON CEO Patrick W. Smith sell in the Form 4 filing?

The Form 4 reports the sale of Axon Enterprise, Inc. common stock. The transaction covers 10,000 shares of this common stock, classified as a non-derivative security, sold in an open-market transaction on February 25, 2026.